EXAS · As filed with the SEC

Exact Sciences cash flow statement, by quarter

The statement as Exact Sciences presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Statements of Cash Flows · USD thousands

USD thousands	Q4 2025^† 3 months ended Dec 31, 2025	Q3 2025^† 3 months ended Sep 30, 2025	Q2 2025^† 3 months ended Jun 30, 2025	Q1 2025 3 months ended Mar 31, 2025
Cash flows from operating activities:
Net loss	(85,955)^†	(19,594)^†	(1,185)^†	(101,215)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	32,114^†	31,708^†	31,097^†	29,960
Equity Securities, FV-NI, Gain (Loss)	(3,736)^†	7,581^†	2,136^†	(2,900)
Deferred tax benefit	(1,032)^†	501^†	(6)^†	(1,007)
Share-Based Payment Arrangement, Noncash Expense	55,642^†	51,623^†	55,783^†	54,618
Gain on settlements of convertible notes, net	0^†	0^†	—	—
Amortization of Intangible Assets	24,239^†	24,174^†	24,186^†	24,101
Impairment of long-lived and indefinite-lived assets	406^†	543^†	0^†	6,251
Gain (Loss) On Contingent Consideration From Disposition Of Asset	0^†	0^†	0^†	0
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	4,905^†	8,705^†	4,909^†	8,287
Non-cash lease expense	6,792^†	6,765^†	6,730^†	6,753
Other Noncash Income (Expense)	(1,971)^†	2,873^†	3,993^†	2,001
Changes in assets and liabilities, net of effects of acquisition:
Accounts receivable, net	7,342^†	46,853^†	(73,014)^†	(30,072)
Inventory, net	(1,416)^†	6,713^†	5,106^†	(14,175)
Operating lease liabilities	(7,424)^†	(7,276)^†	(7,266)^†	(6,575)
Accounts payable and accrued liabilities	48,859^†	67,135^†	39,415^†	58,633
Increase (Decrease) in Other Operating Assets	6,400^†	(7,407)^†	(8,624)^†	3,837
Increase (Decrease) in Other Operating Liabilities	8,440^†	(626)^†	(7,219)^†	(5,814)
Net cash provided by operating activities	151,689^†	219,923^†	89,017^†	30,809
Cash flows from investing activities:
Purchases of marketable securities	0^†	(46,473)^†	(13,481)^†	(80,315)
Maturities and sales of marketable securities	201,795^†	40,053^†	252,872^†	77,557
Purchases of property, plant and equipment	(31,243)^†	(29,897)^†	(42,342)^†	(31,174)
Proceeds From Contingent Consideration Receivable	0^†	0^†	—	—
Payments to Acquire Other Investments	(4,435)^†	(50,289)^†	—	—
Other investing activities	0^†	152^†	650^†	(505)
Net cash provided by (used in) investing activities	91,117^†	(86,454)^†	224,895^†	(34,437)
Cash flows from financing activities:
Proceeds in connection with the Company's employee stock purchase plan	10,511^†	0^†	—	—
Proceeds from issuance of convertible notes	0^†	0^†	—	—
Repayments of Accounts Receivable Securitization	0^†	0^†	—	—
Repayments of convertible debt	498,344^†	0^†	0^†	(249,172)
Payment, Tax Withholding, Share-Based Payment Arrangement	—	209^†	293^†	(422)
Payment for Contingent Consideration Liability, Financing Activities	0^†	0^†	—	—
Other financing activities	(1,729)^†	(1,741)^†	(1,840)^†	(6,577)
Net cash provided by (used in) financing activities	(75,873)^†	(1,532)^†	(4,514)^†	(256,171)
Effects of exchange rate changes on cash and cash equivalents	26^†	1^†	574^†	290
Net increase (decrease) in cash, cash equivalents, and restricted cash	166,959^†	131,938^†	309,972^†	(259,509)
Cash, cash equivalents, and restricted cash, beginning of period	789,037	657,099	347,127	606,636
Cash, cash equivalents, and restricted cash, end of period	955,996	789,037	657,099	347,127
Non-cash investing and financing activities:
Property, plant and equipment acquired but not paid	5,509^†	(3,351)^†	(3,399)^†	17,523
Stock Issued During Period, Value, Employee Benefit Plan	0^†	0^†	0^†	43,943
Supplemental disclosure of cash flow information:
Interest paid	6,163^†	8,646^†	6,162^†	9,473

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.